Cargando…

Correction to: Disability assessment using Google Maps

Detalles Bibliográficos
Autores principales:	Lavorgna, Luigi, Iaffaldano, Pietro, Abbadessa, Gianmarco, Lanzillo, Roberta, Esposito, Sabrina, Ippolito, Domenico, Sparaco, Maddalena, Cepparulo, Simone, Lus, Giacomo, Viterbo, Rosa, Clerico, Marinella, Trojsi, Francesca, Ragonese, Paolo, Borriello, Giovanna, Signoriello, Elisabetta, Palladino, Raffaele, Moccia, Marcello, Brigo, Francesco, Troiano, Maria, Tedeschi, Gioacchino, Bonavita, Simona
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2021
Materias:	Correction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9119253/ https://www.ncbi.nlm.nih.gov/pubmed/34727256 http://dx.doi.org/10.1007/s10072-021-05707-z

Ejemplares similares

Disability assessment using Google Maps
por: Lavorgna, Luigi, et al.
Publicado: (2021)

Public Engagement and Neurology: An Update
por: Lavorgna, Luigi, et al.
Publicado: (2021)

Assessment of Multiple Sclerosis Disability Progression Using a Wearable Biosensor: A Pilot Study
por: Abbadessa, Gianmarco, et al.
Publicado: (2021)

Right phrenic nerve palsy following transcatheter radiofrequency current atrial fibrillation ablation: Case report
por: Abbadessa, Gianmarco, et al.
Publicado: (2019)

Multiple sclerosis and genetic polymorphisms in fibrinogen-mediated hemostatic pathways: a case–control study
por: Abbadessa, Gianmarco, et al.
Publicado: (2021)

The Use of Social Media and Digital Devices Among Italian Neurologists
por: Lavorgna, Luigi, et al.
Publicado: (2020)

Digital therapeutics in neurology
por: Abbadessa, G., et al.
Publicado: (2021)

Digital work engagement among Italian neurologists
por: Brigo, Francesco, et al.
Publicado: (2021)

Social Media and Multiple Sclerosis in the Posttruth Age
por: Lavorgna, Luigi, et al.
Publicado: (2017)

Clinically Manifest Infections Do Not Increase the Relapse Risk in People with Multiple Sclerosis Treated with Disease-Modifying Therapies: A Prospective Study †
por: Miele, Giuseppina, et al.
Publicado: (2023)

Myasthenia gravis and telemedicine: a lesson from COVID-19 pandemic
por: Ricciardi, Dario, et al.
Publicado: (2021)

Association between relapses, stress, and depression in people with multiple sclerosis during the COVID-19 pandemic
por: Sparaco, Maddalena, et al.
Publicado: (2022)

Telemedicine for management of patients with amyotrophic lateral sclerosis through COVID-19 tail
por: Bombaci, Alessandro, et al.
Publicado: (2020)

The Role of Wearable Devices in Multiple Sclerosis
por: Sparaco, Maddalena, et al.
Publicado: (2018)

Assessing disability and relapses in multiple sclerosis on tele-neurology
por: Moccia, Marcello, et al.
Publicado: (2020)

CD19 Cell Count at Baseline Predicts B Cell Repopulation at 6 and 12 Months in Multiple Sclerosis Patients Treated with Ocrelizumab
por: Abbadessa, Gianmarco, et al.
Publicado: (2021)

How to manage with telemedicine people with neuromuscular diseases?
por: Spina, Emanuele, et al.
Publicado: (2021)

Stroke and digital technology: a wake-up call from COVID-19 pandemic
por: Iodice, Francesco, et al.
Publicado: (2021)

Telemedicine and the challenge of epilepsy management at the time of COVID-19 pandemic()
por: Brigo, Francesco, et al.
Publicado: (2020)

Telemedicine application to headache: a critical review
por: Spina, Emanuele, et al.
Publicado: (2022)

Prognostic Markers of Ocrelizumab Effectiveness in Multiple Sclerosis: A Real World Observational Multicenter Study
por: Lanzillo, Roberta, et al.
Publicado: (2022)

Repetitive Transcranial Magnetic Stimulation (rTMS) in Mild Cognitive Impairment: Effects on Cognitive Functions—A Systematic Review
por: Sharbafshaaer, Minoo, et al.
Publicado: (2023)

Genetics and Sex in the Pathogenesis of Amyotrophic Lateral Sclerosis (ALS): Is There a Link?
por: Trojsi, Francesca, et al.
Publicado: (2020)

Sexual Dysfunction in People with Multiple Sclerosis: The Role of Disease Severity, Illness Perception, and Depression
por: Scandurra, Cristiano, et al.
Publicado: (2023)

Disease Reactivation in Secondary Progressive Multiple Sclerosis Patients Switching from Fingolimod to Siponimod: A Case Series
por: Abbadessa, Gianmarco, et al.
Publicado: (2022)

Google Maps Timeline: An open-access digital tool to monitor walking abilities in people with multiple sclerosis
por: Caliendo, Daniele, et al.
Publicado: (2023)

Digital triage for people with multiple sclerosis in the age of COVID-19 pandemic
por: Bonavita, Simona, et al.
Publicado: (2020)

Associations between cognitive impairment at onset and disability accrual in young people with multiple sclerosis
por: Carotenuto, Antonio, et al.
Publicado: (2019)

Healthcare resource utilization and costs for multiple sclerosis management in the Campania region of Italy: Comparison between centre-based and local service healthcare delivery
por: Moccia, Marcello, et al.
Publicado: (2019)

Editorial: Digital Technology in Neurology: From Clinical Assessment to Neurorehabilitation
por: Moccia, Marcello, et al.
Publicado: (2021)

Viral pericarditis following ocrelizumab in a multiple sclerosis patient
por: Miele, Giuseppina, et al.
Publicado: (2023)

Editorial: Bridging the gap between basic neurosciences and clinical neuroimmunology
por: Abbadessa, Gianmarco, et al.
Publicado: (2023)

Dementia care and COVID-19 pandemic: a necessary digital revolution
por: Cuffaro, Luca, et al.
Publicado: (2020)

Physical Exercise Moderates the Effects of Disability on Depression in People with Multiple Sclerosis during the COVID-19 Outbreak
por: Carotenuto, Antonio, et al.
Publicado: (2021)

Alemtuzumab-Related Lymphocyte Subset Dynamics and Disease Activity or Autoimmune Adverse Events: Real-World Evidence
por: Signoriello, Elisabetta, et al.
Publicado: (2023)

Is It Time for Ocrelizumab Extended Interval Dosing in Relapsing Remitting MS? Evidence from An Italian Multicenter Experience During the COVID-19 Pandemic
por: Zanghì, Aurora, et al.
Publicado: (2022)

Multidimensional assessment of the effects of erenumab in chronic migraine patients with previous unsuccessful preventive treatments: a comprehensive real-world experience
por: Russo, Antonio, et al.
Publicado: (2020)

Exit Strategies in Natalizumab-Treated RRMS at High Risk of Progressive Multifocal Leukoencephalopathy: a Multicentre Comparison Study
por: Zanghì, Aurora, et al.
Publicado: (2021)

Long-Term Neuromodulatory Effects of Repetitive Transcranial Magnetic Stimulation (rTMS) on Plasmatic Matrix Metalloproteinases (MMPs) Levels and Visuospatial Abilities in Mild Cognitive Impairment (MCI)
por: Cirillo, Giovanni, et al.
Publicado: (2023)

Apparently isolated CNS involvement in Erdheim-Chester disease: Case report
por: Romano, Giuseppe, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_q8bqjvehi0hg1oa58oepuf4i56